Trials / No Longer Available
No Longer AvailableNCT05235347
Sotrovimab Expanded Access Treatment Protocol (COVID-19)
Sotrovimab Expanded Access Treatment Protocol
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Vir Biotechnology, Inc. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- —
Summary
An expanded access program for sotrovimab administered intravenously to participants with COVID-19 illness who meet current authorized/approved criteria for use of sotrovimab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Sotrovimab | 500mg IV |
Timeline
- First posted
- 2022-02-11
- Last updated
- 2022-11-10
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05235347. Inclusion in this directory is not an endorsement.